Exscientia plc(NASDAQ:EXAI) 
Exscientia Limited, an artificial intelligence-powered pharmaceutical technology company, is dedicated to drug discovery, design and development. The company is headquartered in Oxford, the United Kingdom.
Website: https://www.exscientia.ai/
Founded: 2012
IPO Price: $22 (Oct 01, 2021)
CEO / Founder: Andrew Hopkins
Sector:
Industry:
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
😊
Day
Week
Month
Date 2024-05-24
P
O 4.78
H 4.87
L 4.67
C 4.69
V 381,516
10EMA 4.69
20EMA 4.69
60EMA 4.69
120EMA 4.69
250EMA 4.69